This leads us to hypothesize that immune cells in addition to macrophages and CD8+ T-cells are likely to be contributing to the GR signature of the bulk tumor, though none of the immune cells were independently elevated in GR-high breast cancer. The gene discussed is CD8A; the disease is neoplasm.